- Home
- AFBI vs DERM Comparison
AFBI vs DERM Comparison
Compare AFBI & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFBI
- DERM
- Stock Information
- Founded
- AFBI 1928
- DERM 2014
- Country
- AFBI United States
- DERM United States
- Employees
- AFBI N/A
- DERM N/A
- Industry
- AFBI Major Banks
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- AFBI Finance
- DERM Health Care
- Exchange
- AFBI Nasdaq
- DERM Nasdaq
- Market Cap
- AFBI 117.9M
- DERM 95.0M
- IPO Year
- AFBI N/A
- DERM 2021
- Fundamental
- Price
- AFBI $18.73
- DERM $5.19
- Analyst Decision
- AFBI
- DERM Strong Buy
- Analyst Count
- AFBI 0
- DERM 3
- Target Price
- AFBI N/A
- DERM $9.50
- AVG Volume (30 Days)
- AFBI 12.8K
- DERM 55.0K
- Earning Date
- AFBI 01-31-2025
- DERM 03-20-2025
- Dividend Yield
- AFBI N/A
- DERM N/A
- EPS Growth
- AFBI N/A
- DERM N/A
- EPS
- AFBI 0.83
- DERM N/A
- Revenue
- AFBI $30,608,000.00
- DERM $57,771,000.00
- Revenue This Year
- AFBI N/A
- DERM N/A
- Revenue Next Year
- AFBI N/A
- DERM $36.49
- P/E Ratio
- AFBI $22.57
- DERM N/A
- Revenue Growth
- AFBI 3.04
- DERM N/A
- 52 Week Low
- AFBI $14.93
- DERM $2.85
- 52 Week High
- AFBI $22.50
- DERM $6.89
- Technical
- Relative Strength Index (RSI)
- AFBI 51.32
- DERM 60.26
- Support Level
- AFBI $18.34
- DERM $4.85
- Resistance Level
- AFBI $19.11
- DERM $5.37
- Average True Range (ATR)
- AFBI 0.24
- DERM 0.40
- MACD
- AFBI 0.13
- DERM 0.02
- Stochastic Oscillator
- AFBI 62.38
- DERM 70.49
About AFBI Affinity Bancshares Inc. (MD)
Affinity Bancshares Inc is a holding company of Affinity Bank, a federally chartered stock savings bank that offers a variety of deposit accounts, including checking accounts, savings accounts, and certificate of deposit accounts. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate loans, commercial and industrial loans, and residential real estate loans, construction and land loans, and consumer loans. It also invests in securities, which consist of mortgage-backed securities and obligations issued by United States government-sponsored enterprises and Federal Home Loan Bank stock.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.